Overview of breast cancer collaborative stage data items-their definitions, quality, usage, and clinical implications: A review of SEER data for 2004-2010

Breast Cancer

(2017) Robert W. Carlson et al.   Journal of the National Comprehensive Cancer Network

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Use of Imputed Population-based Cancer Registry Data as a Method of Accounting for Missing Information: Application to Estrogen Receptor Status for Breast Cancer

(2012) Nadia Howlader et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Age-Specific Incidence of Breast Cancer Subtypes: Understanding the Black–White Crossover

(2012) Christina A. Clarke et al.   JNCI-Journal of the National Cancer Institute

Breast cancer statistics, 2011

(2011) Carol DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining

(2011) C. DeSantis et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Incidence of Breast Cancer in the United States: Current and Future Trends

(2011) W. F. Anderson et al.   JNCI-Journal of the National Cancer Institute

Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer

(2010) Katrina Bauer et al.   BMC CANCER

Feasibility Study for Collection of HER2 Data by National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program Central Cancer Registries

(2010) M. E. Reichman et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999-2004

(2009) Carol A. Parise et al.   Breast Journal